PDB36 Reduced Rates of Hypoglycemia Lead to Cost Savings for Type 2 Diabetic Patients Treated with Saxagliptin Versus Sulphonlyurea in Actual Clinical Practice
Jun 1, 2012, 00:00 AM
10.1016/j.jval.2012.03.957
https://www.valueinhealthjournal.com/article/S1098-3015(12)01022-4/fulltext
Section Title :
Diabetes/Endocrine Disorders
Section Order :
456
First Page :
A177
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01022-4&doi=10.1016/j.jval.2012.03.957